CytoPherx Inc. has raised $5 million of an anticipated $7.5 million Series B round to develop a device that filters the blood of kidney disease patients. The funding will go toward a clinical trial of the Ann Arbor, Mich. company’s hollow-fiber dialysis filters, which are used to isolate and deactivate white blood cells in a […]
Biotechnology company NephRx Corp. has raised $6.2 million in equity. The preclinical stage company is working to develop drugs to treat kidney failure, plus diseases of the gastrointestinal tract, including mucositis, Crohn’s Disease and ulcerative colitis.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.